Added to YB: 2026-07-03
Pitch date: 2026-07-01
NRXS [neutral]
NeurAxis, Inc.
+2.17%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$90.5M
Pitch Price
$6.91
Price Target
25.00 (+253%)
Dividend
N/A
EV/EBITDA
-11.81
P/E
-9.01
EV/Sales
19.57
Sector
Health Care Equipment and Supplies
Category
growth
Microcap Opportunities | Multibaggers - NeurAxis, Inc.
NRXS (holding update): Neuromodulation play +129.9% since Aug'24 add. CPT code 64567 went Category I Jan'26 w/ CMS pricing, 100M+ covered lives; PA requests ~10x YoY. Q1'26 rev $1.6M (+79.5%). VA Federal Supply Schedule (170+ centers, no PA) not yet in models. 2027 PT $25. Q2 earnings Aug key catalyst.
Read full article (1 min)